Table 3. Summary of case series and cohort studies describing response of HIV-1/2 dual-infected patients on ART in the HAART era. Individual case reports excluded, but are discussed in the main text.

Ascertainment of vital status was good in this close-knit rural West African community, with a total loss to follow up of only 6.5%. However, follow up sampling for laboratory tests was less ...

HIV-2 and HIV-1 are both types of human immunodeficiency virus (HIV). They are both transmitted the same way, but HIV-2 does not spread as easily and progresses to AIDS more slowly. Those with HIV-2 ...

Prevention—what doesn’t work? In a session entitled “Status of the U.S. HIV/AIDS Epidemic: Is It Changing and If Not, Why Not?” Harold Jaffe, MD, former head of the CDC, discussed a not-yet-published ...

The HIV prevention shot lenacapavir will be rolled out at South African clinics within the next couple of months — from 2027, ...

What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best option for them?

Twice-yearly lenacapavir (Sunlenca) substantially reduced HIV infection when used for preexposure prophylaxis (PrEP) in cisgender men and transgender or gender-nonbinary persons in the pivotal PURPOSE ...

Share on Pinterest A drug used to treat HIV infections can also effectively prevent them, a new clinical trial demonstrates. Image credit: luza studios/Getty Images. Human immunodeficiency virus (HIV) ...

Mr. R, a 22-year-old gay man, presents with a maculopapular rash of broad distribution involving the palms and soles. A review of systems reveals that eight weeks prior to this examination, he had a ...